| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.08B | 58.76B | 52.76B | 48.37B | 44.45B | 39.71B |
| Gross Profit | 11.84B | 11.44B | 10.13B | 9.43B | 8.52B | 7.07B |
| EBITDA | 6.58B | 6.61B | 5.64B | 5.49B | 4.90B | 3.88B |
| Net Income | 4.40B | 4.41B | 3.73B | 3.33B | 3.24B | 2.63B |
Balance Sheet | ||||||
| Total Assets | 42.62B | 43.34B | 39.71B | 33.64B | 33.14B | 30.34B |
| Cash, Cash Equivalents and Short-Term Investments | 15.01B | 16.15B | 15.90B | 11.86B | 12.88B | 11.56B |
| Total Debt | 1.69B | 1.72B | 2.39B | 1.03B | 1.57B | 1.92B |
| Total Liabilities | 11.82B | 12.52B | 12.03B | 9.19B | 11.00B | 10.86B |
| Stockholders Equity | 30.79B | 30.82B | 27.68B | 24.45B | 22.13B | 19.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.35B | 3.03B | 1.39B | 3.12B | 3.08B |
| Operating Cash Flow | 0.00 | 4.76B | 3.21B | 1.68B | 3.22B | 3.16B |
| Investing Cash Flow | 0.00 | -2.29B | 1.45B | -874.88M | -1.16B | -47.41M |
| Financing Cash Flow | 0.00 | -2.08B | -723.69M | -1.63B | -1.35B | -1.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥65.89B | 18.88 | 17.96% | 1.83% | 13.23% | 16.07% | |
77 Outperform | ¥72.83B | 7.46 | ― | 3.28% | 5.28% | 28.90% | |
77 Outperform | ¥88.67B | 19.07 | ― | 2.32% | 5.09% | 26.12% | |
72 Outperform | ¥57.64B | 11.56 | 16.12% | 2.91% | 10.02% | 16.48% | |
65 Neutral | ¥30.97B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |